Abstract:
Cancers that initially respond to chemotherapy may develop resistance, leading to unexpected tumor growth. This phenomenon, known as chemotherapy resistance, renders the treatment ineffective in eradicating cancer cells. This situation is profoundly disheartening for everyone involved, from patients to medical professionals, as it negates the progress made by previous treatments. Consequently, it is imperative to alter the therapeutic regimen when tumors cease responding to the current chemotherapy. Oncologists must have a thorough understanding of the factors contributing to drug resistance in their patients to provide effective treatment. The importance of monitoring chemotherapy resistance has increasingly become a focal point in oncology. The extent to which oncologists monitor chemo-resistance is influenced by their knowledge of the subject, their attitudes, and their clinical approaches. In light of this, a recent educational initiative aims to enhance the understanding of chemotherapy resistance among oncology healthcare professionals.
Audience Take Away Notes:
- The current presentation is being conducted to improve the level of knowledge of oncology health professionals about chemotherapy resistance
- The current presentation aims to play a substantial role in mitigating and potentially overcoming the occurrence of chemotherapy resistance
- The purpose of this presentation is to introduce the audience to an innovative assessment tool, devised by our research team, designed to gauge the knowledge, attitudes, and practices of healthcare professionals working in the field of oncology regarding chemotherapy resistance
